Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial
- 1 October 2007
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 154 (4), 710.e1-710.e8
- https://doi.org/10.1016/j.ahj.2007.07.003
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- Intracoronary Bone Marrow Cell Transfer After Myocardial InfarctionCirculation, 2006
- Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trialThe Lancet, 2006
- Improved Exercise Capacity and Ischemia 6 and 12 Months After Transendocardial Injection of Autologous Bone Marrow Mononuclear Cells for Ischemic CardiomyopathyCirculation, 2004
- Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialThe Lancet, 2004
- Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in HumansCirculation, 2002
- Three year mortality in heart failure patients with very low left ventricular ejection fractionsInternational Journal of Cardiology, 1999
- Clinical, Hemodynamic, and Cardiopulmonary Exercise Test Determinants of Survival in Patients Referred for Evaluation of Heart FailureAnnals of Internal Medicine, 1998
- Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failureThe American Journal of Cardiology, 1981